Business Context and Reporting Period
Company: Cognex Corporation
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2001
Business Overview: Cognex designs, develops, and markets machine vision systems used to automate manufacturing processes. The company operates two divisions: the Modular Vision Systems Division (MVSD), which controls the manufacturing of discrete items (83% of 2001 revenue), and the Surface Inspection Systems Division (SISD), which inspects continuous materials. The company serves Original Equipment Manufacturers (OEMs) and end-users globally, with 63% of revenue derived from outside the United States.
Key Financial Metrics
| Metric (in thousands) | 2001 | 2000 |
|---|---|---|
| Revenue | $140,729 | $250,726 |
| Gross Margin | $78,384 (56%) | $186,906 (75%) |
| Operating Income (Loss) | $(27,340) | $89,686 |
| Net Income (Loss) | $(11,127) | $68,148 |
| Diluted EPS | $(0.25) | $1.49 |
| Working Capital | $143,712 | $167,913 |
| Total Assets | $406,904 | $436,141 |
| Cash, Equivalents & Investments | $292,715 | $277,740 |
| Long-term Debt | $0 | $0 |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 44% to $140.7 million, driven by a 61% drop in sales to OEM customers in the semiconductor and electronics industries due to a global slowdown in capital spending. End-user sales also declined 16%.
- Impairment Charges: The company recorded significant non-cash charges in Q4 2001:
- $16.3 million charge for excess inventory and purchase commitments.
- $10.9 million charge for intangible asset impairment (primarily goodwill from 2000 acquisitions of Komatsu and Honeywell).
- Margin Compression: Gross margin fell from 75% in 2000 to 56% in 2001. Approximately 12 percentage points of this decline were attributable to the inventory and intangible asset impairment charges. The remaining decline was due to lower sales volume over fixed costs and a shift to lower-margin service and surface inspection revenue.
- Profitability: The company swung from an operating profit of $89.7 million in 2000 to an operating loss of $27.3 million in 2001.
Guidance, Outlook, and Risks
Outlook: Management anticipates continued negative impacts from the semiconductor and electronics slowdown in Q1 2002.
- Q1 2002 Revenue Guidance: $21.0 million to $23.0 million (compared to $25.2 million in Q4 2001).
- Q1 2002 EPS Guidance: Loss of $0.05 to $0.08 per diluted share.
- Full Year 2002: Management expects to report a loss for the full year if business continues at current order rates.
Risks and Contingencies:
- Industry Concentration: 54% of revenue is derived from the semiconductor and electronics industries, which are highly cyclical.
- Legal Proceedings: Ongoing litigation with the Lemelson Medical, Educational, & Research Foundation regarding patent infringement claims. A trial is expected to commence in August 2002.
- Supply Chain: Reliance on third-party contract manufacturers and single-source suppliers for certain components.
- Accounting Changes: Adoption of SFAS No. 142 in 2002 will cease the amortization of goodwill, requiring future impairment testing instead.
Investor Verification Checklist
- Inventory Valuation: Verify the adequacy of the $16.3 million inventory write-down and the remaining inventory balance of $23.1 million given the cyclical downturn.
- Goodwill Impairment: Assess the remaining goodwill balance ($5.7 million) and the methodology used for the $10.9 million impairment charge.
- Customer Concentration: Monitor the top five customers (15% of 2001 revenue) and the specific impact of the semiconductor industry slowdown on OEM orders.
- Lemelson Litigation: Track the status of the patent infringement lawsuit and potential indemnification requests from customers.
- Cash Position: Confirm the liquidity position of $292.7 million in cash and investments is sufficient to sustain operations through the projected 2002 losses without additional financing.